Clinical Trials

NCT05126758 | ACTIVE_NOT_RECRUITING | PHASE3

106 participants

A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-06-22

Completion:

2025-06-18

Conditions

• Muscular Dystrophies
• Muscular Dystrophy, Duchenne
• Muscular Disorders, Atrophic
• Muscular Diseases
• Neuromuscular Diseases
• Genetic Diseases, X-Linked
• Genetic Diseases, Inborn
• Nervous System Diseases

Interventions

• BIOLOGICAL

No Results Yet

NCT05119231 | ACTIVE_NOT_RECRUITING | NA

262 participants

Pulmonary Vein Isolation vs SHAM-pulmonary Vein Isolation for Symptomatic Relief in Patients With AF

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-11-12

Completion:

2026-06-01

Conditions

• Atrial Fibrillation

Interventions

• PROCEDURE
• OTHER

No Results Yet

NCT05108298 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1

500 participants

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-11-10

Completion:

2027-05-01

Conditions

• Hematopoietic and Lymphatic System Neoplasm
• Malignant Solid Neoplasm

Interventions

• OTHER

No Results Yet

NCT05104736 | RECRUITING | PHASE2

53 participants

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-04-06

Completion:

2027-12-31

Conditions

• Thymic Epithelial Tumor
• Recurrent Thymoma
• Thymic Cancer

Interventions

• DRUG

No Results Yet

NCT05099003 | RECRUITING | PHASE1/PHASE2

132 participants

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-05-31

Completion:

2027-06-30

Conditions

• Malignant Glioma

Interventions

• PROCEDURE
• RADIATION
• DRUG

No Results Yet

NCT05092269 | ACTIVE_NOT_RECRUITING | PHASE3

159 participants

A Long-term Extension Study of Ustekinumab in Pediatric Participants

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-10-18

Completion:

2027-09-29

Conditions

• Crohn Disease
• Colitis, Ulcerative
• Arthritis, Psoriatic

Interventions

• DRUG

No Results Yet

NCT05083169 | ACTIVE_NOT_RECRUITING | PHASE3

587 participants

A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-10-14

Completion:

2025-09-15

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT05058638 | RECRUITING | PHASE2

25 participants

Effectiveness of Aquamin® in Mitigating Halitosis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-08-15

Completion:

2027-12-31

Conditions

• Healthy
• Halitosis

Interventions

• DRUG

No Results Yet

NCT05050097 | ACTIVE_NOT_RECRUITING | PHASE1

166 participants

A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-09-22

Completion:

2025-03-31

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT05049798 | ACTIVE_NOT_RECRUITING

1314 participants

A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2021-08-25

Completion:

2027-08-01

Conditions

• Arthritis, Psoriatic

Interventions

• DRUG

No Results Yet

NCT04989803 | RECRUITING | PHASE1/PHASE2

247 participants

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-10-27

Completion:

2030-02-28

Conditions

• Relapsed and/or Refractory B-cell Lymphoma

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT04971226 | ACTIVE_NOT_RECRUITING | PHASE3

405 participants

A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-10-06

Completion:

2023-11-28

Conditions

• Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive

Interventions

• DRUG

Results Available

NCT04959253 | COMPLETED | PHASE2

60 participants

Psilocybin in Depression Resistant to Standard Treatments

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-06-21

Completion:

2024-12-18

Conditions

• Treatment Resistant Depression

Interventions

• COMBINATION_PRODUCT

No Results Yet

NCT04957550 | ACTIVE_NOT_RECRUITING | PHASE3

418 participants

To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-08-30

Completion:

2026-12-13

Conditions

• Psoriatic Arthritis

Interventions

• DRUG

No Results Yet

NCT04936685 | ACTIVE_NOT_RECRUITING | PHASE3

209 participants

Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-08-23

Completion:

2023-03-09

Conditions

• Meningococcal Immunisation
• Healthy Volunteers

Interventions

• BIOLOGICAL

Results Available

NCT04929210 | ACTIVE_NOT_RECRUITING | PHASE4

411 participants

A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-08-30

Completion:

2027-04-01

Conditions

• Arthritis, Psoriatic

Interventions

• DRUG

No Results Yet

NCT04923893 | ACTIVE_NOT_RECRUITING | PHASE3

743 participants

A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-08-19

Completion:

2029-02-14

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT04896060 | COMPLETED

5056 participants

The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2022-09-01

Completion:

2025-02-13

Conditions

• COVID-19
• Obesity

No Results Yet

NCT04892173 | RECRUITING | PHASE3

500 participants

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-12-10

Completion:

2028-06-30

Conditions

• Carcinoma, Squamous Cell

Interventions

• DRUG
• RADIATION

No Results Yet

NCT04882098 | ACTIVE_NOT_RECRUITING | PHASE3

1054 participants

A Study of Guselkumab in Participants With Active Psoriatic Arthritis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-06-17

Completion:

2024-12-30

Conditions

• Arthritis, Psoriatic

Interventions

• DRUG

Results Available

NCT04863573 | ACTIVE_NOT_RECRUITING

1000 participants

COVID-19 Antibody Responses In Cystic Fibrosis

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2021-11-19

Completion:

2027-08-31

Conditions

• Covid19
• Cystic Fibrosis

No Results Yet

NCT04816591 | COMPLETED | NA

376 participants

Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-05-27

Completion:

2024-08-15

Conditions

• Chronic Subdural Hematoma

Interventions

• DEVICE
• OTHER

Results Available

NCT04811560 | RECRUITING | PHASE1/PHASE2

420 participants

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-05-19

Completion:

2027-02-26

Conditions

• Acute Leukemia

Interventions

• DRUG

No Results Yet

NCT04802590 | ACTIVE_NOT_RECRUITING | PHASE2

210 participants

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-01-24

Completion:

2025-05-27

Conditions

• Mantle Cell Lymphoma

Interventions

• DRUG

No Results Yet

NCT04799301 | RECRUITING | PHASE1

60 participants

Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-02-23

Completion:

2028-01-01

Conditions

• Diet Therapy
• Healthy Volunteers

Interventions

• BEHAVIORAL

No Results Yet

NCT04794101 | ACTIVE_NOT_RECRUITING | PHASE3

97 participants

Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-12-04

Completion:

2029-09-20

Conditions

• X-Linked Retinitis Pigmentosa

Interventions

• BIOLOGICAL

No Results Yet

NCT04793217 | COMPLETED | NA

350 participants

A Randomized Trial of ImpACT+, a Coping Intervention for HIV Infected Women With Sexual Trauma in South Africa

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-02-18

Completion:

2025-07-03

Conditions

• HIV
• Trauma Exposure

Interventions

• BEHAVIORAL

Results Available

NCT04787341 | COMPLETED | PHASE2

213 participants

PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-12-15

Completion:

2025-08-07

Conditions

• Colorectal Cancer

Interventions

• DRUG

No Results Yet

NCT04785677 | COMPLETED | NA

403 participants

Researching Resiliency in Stressful Experiences (RISE) Program for Men Leaving Incarceration

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-02-09

Completion:

2023-05-30

Conditions

• Stress Disorders, Traumatic
• Stress Disorders, Traumatic, Acute
• Depressive Symptoms
• Anxiety
• Substance Use
• Aggression
• Coping Skills
• Impulsive Behavior
• Housing Problems
• Recidivism
• Stress
• Occupational Stress
• Psychological Distress

Interventions

• BEHAVIORAL

Results Available

NCT04773548 | COMPLETED | NA

12 participants

Feasibility and Safety of a Virtual-Reality Based Job Interview Training Tool in Teenagers With High-Functioning Autism

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2018-10-24

Completion:

2020-10-24

Conditions

• Autism Spectrum Disorder

Interventions

• OTHER

No Results Yet

NCT04750798 | RECRUITING

8000 participants

An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2021-02-22

Completion:

2036-12-31

Conditions

• Arrhythmias, Cardiac

Interventions

• DEVICE

No Results Yet

NCT04747314 | COMPLETED | PHASE2

308 participants

Treating Negative Affect in Low Back Pain Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-03-31

Completion:

2024-11-04

Conditions

• Chronic Low Back Pain
• Negative Affectivity

Interventions

• DRUG
• OTHER

Results Available

NCT04722263 | RECRUITING | NA

15 participants

Radiotherapy for Keloids

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-12-01

Completion:

2027-04-30

Conditions

• Keloid

Interventions

• RADIATION

No Results Yet

NCT04722146 | ACTIVE_NOT_RECRUITING | PHASE1

140 participants

A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-03-12

Completion:

2025-10-03

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT04721691 | COMPLETED | PHASE1

16 participants

Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-03-10

Completion:

2024-01-17

Conditions

• Electrical Status Epilepticus of Slow-Wave Sleep

Interventions

• DRUG
• OTHER

No Results Yet

NCT04677816 | RECRUITING | PHASE2

50 participants

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-10-22

Completion:

2026-12-31

Conditions

• Triple Negative Breast Cancer
• Vitamin D Deficiency
• Invasive Breast Cancer

Interventions

• DRUG
• DIETARY_SUPPLEMENT
• OTHER

No Results Yet

NCT04662580 | ACTIVE_NOT_RECRUITING | PHASE1

183 participants

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-05-03

Completion:

2026-12-31

Conditions

• Metastatic Prostate Cancer

Interventions

• DRUG

No Results Yet

NCT04662372 | COMPLETED

40 participants

Functional Neurological Disorders in Patients Admitted in Stroke Units

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2021-03-05

Completion:

2025-10-31

Conditions

• Functional Neurological Disorders

Interventions

• OTHER

No Results Yet

NCT04658862 | ACTIVE_NOT_RECRUITING | PHASE3

518 participants

A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-12-07

Completion:

2026-12-30

Conditions

• Urinary Bladder Neoplasms

Interventions

• BIOLOGICAL
• DRUG
• RADIATION

No Results Yet

NCT04644770 | ACTIVE_NOT_RECRUITING | PHASE1

144 participants

A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-11-12

Completion:

2026-12-08

Conditions

• Prostatic Neoplasms
• Adenocarcinoma

Interventions

• DRUG
• RADIATION

No Results Yet